메뉴 건너뛰기
European Urology
Volumn 54, Issue 6, 2008, Pages 1219-1220
Sequential Therapies in Metastatic Renal Cell Carcinoma: Option or Strategy?
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; INTERLEUKIN 2; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; TEMSIROLIMUS; VASCULOTROPIN INHIBITOR; VON HIPPEL LINDAU PROTEIN;
EID: 55649100501     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.08.066     Document Type: Editorial
Times cited : (6)
References (8)
  • 1
    • 84965188394 scopus 로고    scopus 로고
    • Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev 2005;25:CD001425.
    • Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev 2005;25:CD001425.
  • 2
    • 14644415949 scopus 로고    scopus 로고
    • Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma
    • Rini B.I., and Small E.J. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol 23 (2005) 1028-1043
    • (2005) J Clin Oncol , vol.23 , pp. 1028-1043
    • Rini, B.I.1    Small, E.J.2
  • 3
    • 45849094041 scopus 로고    scopus 로고
    • Update on the medical treatment of metastatic renal cell carcinoma
    • Ravaud A., Wallerand H., Culine S., et al. Update on the medical treatment of metastatic renal cell carcinoma. Eur Urol 54 (2008) 315-325
    • (2008) Eur Urol , vol.54 , pp. 315-325
    • Ravaud, A.1    Wallerand, H.2    Culine, S.3
  • 4
    • 48649107474 scopus 로고    scopus 로고
    • Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
    • RECORD-1 Study Group
    • Motzer R.J., Escudier B., Oudard S., et al., RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372 (2008) 449-456
    • (2008) Lancet , vol.372 , pp. 449-456
    • Motzer, R.J.1    Escudier, B.2    Oudard, S.3
  • 5
    • 36749064602 scopus 로고    scopus 로고
    • Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy
    • Tamaskar I., Garcia J.A., Elson P., et al. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. J Urol 179 (2008) 81-86
    • (2008) J Urol , vol.179 , pp. 81-86
    • Tamaskar, I.1    Garcia, J.A.2    Elson, P.3
  • 6
    • 36549059204 scopus 로고    scopus 로고
    • Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
    • Dham A., and Dudek A.Z. Sequential therapy with sorafenib and sunitinib in renal cell carcinoma. J Clin Oncol 25 Suppl 18S (2007) 5106
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL. 18S , pp. 5106
    • Dham, A.1    Dudek, A.Z.2
  • 7
    • 35549008792 scopus 로고    scopus 로고
    • Sequential use of sorafenib and sunitinib in renal cancer: retrospective analysis in 90 patients
    • Sablin M.P., Bouaita L., Balleyguier C., et al. Sequential use of sorafenib and sunitinib in renal cancer: retrospective analysis in 90 patients. J Clin Oncol 25 Suppl 18S (2007) 5038
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL. 18S , pp. 5038
    • Sablin, M.P.1    Bouaita, L.2    Balleyguier, C.3
  • 8
    • 55649103188 scopus 로고    scopus 로고
    • Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis
    • Eichelberg C., Heuer R., Chun F.K., et al. Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis. Eur Urol. 54 (2008) 1373-1378
    • (2008) Eur Urol. , vol.54 , pp. 1373-1378
    • Eichelberg, C.1    Heuer, R.2    Chun, F.K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.